Andreas Halvorsen's position in Royalty Pharma plc is currently worth $404 Million. That's 1.32% of their equity portfolio (30th largest holding). The investor owns 2.83% of the outstanding Royalty Pharma plc stock. The first Royalty Pharma plc trade was made in Q2 2020. Since then Andreas Halvorsen bought shares twelve more times and sold shares on six occasions. The investor's estimated purchase price is $478 Million, resulting in a loss of 16%.